Would mild hemophilia A that does not require frequent factor replacement be an absolute contraindication to anti-VEGF medications when indicated?

There is one report in the literature of the use of bevacizumab and chemotherapy in a patient with mild Hemophilia B and metastatic colon cancer. The patient tolerated the combination without bleeding and his hematologic monitoring remained unchanged on the combination. The package insert does descr...